$2.01B
Deals

$274.03M
Series A

71
New Companies

CipherBio Weekly Digest: Week of Feb 17 – Feb 23, 2022

Top 5 Deals This Week

Minded, New York-based digital health/AI company, raises $25M in Seed round from various investors. Plexium raises $102M in Series A led by BVF Partners, L.P. and TCG X. Equip Health raises $58M in Series B led by The Chernin Group. In Series E  Somatus raises $325M led by Wellington Management. Sirona Medical acquires Nines for an undisclosed amount.

CompanyRoundAmount
MindedSeed$25M
PlexiumSeries A$102M
Equip HealthSeries B$58M
SomatusSeries E$325M
NinesAcquisitionUndisclosed

Top Deals by Product and Clinical Phases

NovelMed announces phase 1 clinical trial of NM8074. In phase 2 Evelo Biosciences announces trial of EDP1815 in Atopic Dermatitis. Belgium-based Pharmazz announces phase 3 clinical trial of Sovateltide for ischemic stroke. Senseonics announces FDA approval of Eversense E3 CGM System.

CompanyProduct and Clinical PhaseIndications
NovelMedNM8074Phase 1Paroxysmal Nocturnal Hemoglobinuria (PNH)
Evelo BiosciencesEDP1815, Phase 2Atopic Dermatitis, Allergic Diseases
PharmazzSovateltide, Phase 3Ischemic Stroke
SenseonicsPure-Vu® EVS System, FDA ClearedDiabetes

71 Life Science Companies Added

This week we added 71 life science companies to our platform.

Hyphen Semaai NovelMed
Ageless Biotech TargED Biopharmaceuticals High Tide Therapeutics
MediBuddy Heyy ProJenX

To get all the latest life science deals and VC funding data delivered straight to your inbox weekly become a CipherBio PRO member.

You May Also Like

Most Active Corporate VCs in the Life Science Industry

Co-authored by Matt Gibbs CipherBio@svb and Steve Agular SVB Managing Director, VC…
MicroBiome Insights

64 Microbiome Biotechs Raise $1.6 Billion in Investments

In the last decade, a relatively uncharted field exploded in the life…
Cell Therapy Insights

$18 Billion Invested in 135 Cell Therapy Companies

Cell therapy was born in the 1930s when Paul Niehans earned the…
CipherBio 2020 Biotech Industry Report

2020 Biotech Funding Overview

It has been an unprecedented year so far for Biotech industry and…